Hubert Pham
Ophthalmology · Seattle, WANPI 1578880902
Payments from drug & device makers
Across 74 payments — averaging $48.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$1K
- Rxsight Inc$435
- NEW World Medical,inc.$331
- Tarsus Pharmaceuticals, Inc.$315
- Glaukos Corporation$271
- Biotissue Holdings Inc.$235
- plus $992 from 16 others
What the payments were for
- Speaking & faculty fees$391%
- Food & beverage$3,53499%
- Gifts$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 18 | $1,008 |
| Rxsight Inc | 6 | $435 |
| NEW World Medical,inc. | 2 | $331 |
| Tarsus Pharmaceuticals, Inc. | 7 | $315 |
| Glaukos Corporation | 6 | $271 |
| Biotissue Holdings Inc. | 6 | $235 |
| Coopervision Inc. | 1 | $143 |
| Bausch & Lomb Americas Inc. | 6 | $128 |
| Sun Pharmaceutical Industries Inc. | 3 | $122 |
| Apellis Pharmaceuticals, Inc. | 1 | $113 |
| Astellas Pharma US Inc | 1 | $100 |
| Dompe US, Inc. | 3 | $90 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $51 |
| Novartis | 2 | $40 |
| Oyster Point Pharma, Inc. | 2 | $36 |
| Sight Sciences, Inc. | 2 | $32 |
| GSK | 1 | $31 |
| Harrow Eye, LLC | 1 | $27 |
| Thea Pharma Inc. | 1 | $24 |
| Amgen | 1 | $21 |
| AbbVie | 1 | $20 |
| Carl Zeiss Meditec, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AcrySof IQ PanOptix$297
- Clareon$285
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$246
- MiSight Contact Lens$143
- Prokera$137
- XDEMVY$136
- TRYPTYR$115
- Kahook Dual Blade$114
- Streamline Surgical System$114
- Ahmed Glaucoma Valve$114
- Syfovre$113
- KXL System$104
- Photrexa$104
- Izervay$100
How this compares
$3,587 in reported general payments places this provider in the 75th percentile of 428 ophthalmology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 34 | $50,617 |
| XiidraLifitegrast | 12 | $23,428 |
| LumiganBimatoprost | 20 | $7,166 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 15 | $2,734 |
| Latanoprost | 210 | $2,077 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 95 | $1,461 |
| ValacyclovirValacyclovir Hcl | 11 | $984 |
| Brimonidine Tartrate | 48 | $573 |
| Timolol Maleate | 42 | $562 |
| Prednisolone Acetate | 20 | $488 |
| ErythromycinErythromycin Base | 11 | $136 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan | $20 | $57,78354 claims |
| Bausch & Lomb Americas Inc.Xiidra | $128 | $23,42812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 428 ophthalmology providers in Washington.
Other ophthalmology in Seattle
- Laura PerimanSeattle$1.9M
- Sheldon CowenSeattle$560K
- Raghu MudumbaiSeattle$284K
- Jennifer ChaoSeattle$212K
- Kathryn PeppleSeattle$143K
- Debarshi MustafiSeattle$85K
- Michelle CabreraSeattle$75K
- Paul GriggsSeattle$62K
- Aaron KuzinSeattle$59K
- Lisa Olmos de KooSeattle$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.